Sennosides and Docusate Sodium

Manufacturer
Reliable-1 Laboratories LLC
Effective date
2025-01-15
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-06-01 00:52:54

Label at a glance#

ProductSennosides and Docusate Sodium
Active ingredientSENNOSIDES, DOCUSATE SODIUM
Label structure14 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 6 to 12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor do not exceed maximum dosage age starting dosage maximun dosage adults and children 12 years of age or older 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Storage and handling

each tablet contains: calcium 4 mg, sodium 8 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drugs Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Docusate sodium 50 mg

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Stool softener

Stimulant laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

generally produces a bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

this product if you are presently taking mineral oil, unless directed by a doctor

laxative products for longer than 1 week unless directed by a doctor

Warnings

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

stomach pain

nausea

vomiting

noticed a sudden change in bowel habits that continues over a period of 2 weeks

Warnings

OTC - STOP USE SECTION

Stop use and ask a doctor if you have rectal bleeding or fail to have bowel movement after use of a laxative. These may indicate a serious condition.

Warnings

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Warnings

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

do not exceed maximum dosage

agestarting dosagemaximun dosage
adults and children 12 years of age or older2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 4 mg, sodium 8 mg

store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, croscarmellose sodium, D&C Yello #10 Aluminum Lake, FD&C Yellow #6 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Call 516-341-0666

8:30am-4:30pm ET, Mon-Fri

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 69618-065-01

Senna Plus

Sennosides 8.6 mg

Docusate sodium 50 mg

NATURAL VEGETABLE

LAXATIVE AND

STOOL SOFTENER

100 TABLETS

*Compare to active ingredients in SENOKOT-S®

Rev 01 Reliable-1 Senna Plus 100 ctRev 01 Reliable-1 Senna Plus 100 ct

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998740sennosides 8.6 MG / docusate sodium 50 MG Oral TabletPSN7
998740docusate sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSCD7
998740DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSY7

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69618-065-012023-03-29C16284748780-1f386c649-bc9d-0266-e053-dadaa90a7c1aSenna Plus
69618-065-012023-01-30C16284748780-1f386c649-bc9d-0266-e053-dadaa90a7c1aSenna Plus

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69618-065-01Sennosides and Docusate Sodium100 in 1 BOTTLETABLET1007

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69618-065SENNOSIDES AND DOCUSATE SODIUM (SENNOSIDES, DOCUSATE SODIUM) TABLET [RELIABLE-1 LABORATORIES LLC]7Current NDC, Legacy NDC, 1 package rows20250117_a97a1829-f62f-2014-e053-2a95a90a8cc5.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69618-065-01EA - Each69618-06535e11638-08d0-404a-80a4-fbbd3dd082f212021-03-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69618-06569618-065-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sennosides and Docusate SodiumSENNOSIDES, DOCUSATE SODIUMReliable-1 Laboratories LLCa97a1829-f62f-2014-e053-2a95a90a8cc52025-01-15WarningsExact identifier
ndc (package): 69618-065-01
ndc (product): 69618-065
ndc11 (package): 69618006501
spl id: 2bc82d20-1477-46c7-e063-6394a90a0d44
spl set id: a97a1829-f62f-2014-e053-2a95a90a8cc5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.